ライフサイエンスコーパス: left atrial appendage

1 edominantly because of interference from the left atrial appendage.

2 Myofibroblasts were not detected in the left atrial appendage.

3 All patients underwent closure of the left atrial appendage.

4 al ligament disruption, and exclusion of the left atrial appendage.

5 ted in the posterior left atrium than in the left atrial appendage.

6 between the left superior pulmonary vein and left atrial appendage.

7 node to the rest of the atria, ending at the left atrial appendage.

8 eneity in CV was found between the right and left atrial appendages.

9 both MV leaflets), interatrial septum (84%), left atrial appendage (86%), and left ventricle (77%) wa

10 NO* concentration was decreased in the left atrial appendage, although NOS expression was not a

11 sinus, the anterior part of the septum, the left atrial appendage and the superior vena cava.

12 CACs and CSCs were cultured from left atrial appendages and blood samples obtained from p

13 ation of AF, emphasize the importance of the left atrial appendage, and consider challenges and futur

14 paced from the left ventricle (VP, n=29) or left atrial appendage (AP, n=12) to induce CM.

15 l as premature atrial contractions, from the left atrial appendage at a coupling interval of 200 ms i

16 Left atrial appendage closure (LAAC) and nonwarfarin ora

17 dy sought to assess composite data regarding left atrial appendage closure (LAAC) in 2 randomized tri

18 The risk-benefit ratio of left atrial appendage closure (LAAC) versus systemic the

19 Left atrial appendage closure (LAAC) was approved by the

20 was to evaluate the results associated with left atrial appendage closure (LAAC) with the AMPLATZER

21 Atrial Fibrillation) trial demonstrated that left atrial appendage closure (LAAC) with the Watchman d

22 TECT AF trial who underwent attempted device left atrial appendage closure (n=542 patients) and those

23 th AF (PROTECT AF) randomized trial compared left atrial appendage closure against warfarin in atrial

24 Safety data on percutaneous left atrial appendage closure arises from centers with c

25 The implantation of left atrial appendage closure device (WATCHMAN, Boston S

26 ic attack, or thromboembolism) score >/=1, a left atrial appendage closure device is noninferior to l

27 an updated overview of current transcatheter left atrial appendage closure devices and review the res

28 Over the past decade, percutaneous left atrial appendage closure has emerged as a valid alt

29 nvalvular AF at risk for stroke treated with left atrial appendage closure have favorable QOL changes

30 dverse outcomes associated with percutaneous left atrial appendage closure is higher in the real-worl

31 The "local" strategy of left atrial appendage closure is noninferior to "systemi

32 f adverse outcomes and costs of percutaneous left atrial appendage closure procedure in the US.

33 tions, including radiofrequency ablation and left atrial appendage closure procedures for patients wi

34 (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology [ASAP]; NCT0085

35 In the PROTECT AF (Watchman Left Atrial Appendage Closure Technology for Embolic Pro

36 conducted to determine whether percutaneous left atrial appendage closure with a filter device (Watc

37 ficant improvement in the safety of Watchman left atrial appendage closure with increased operator ex

38 Left atrial appendage closure with the device (n = 463)

39 vices and review the results associated with left atrial appendage closure, focusing on procedural an

40 During left atrial appendage closure, the estimated dose absorb

41 In the study, we performed left atrial appendage closure.

42 of experience on the safety of percutaneous left atrial appendage closure.

43 more profound and of longer duration for the left atrial appendage compared with the left atrium as a

44 This study compared left atrial and left atrial appendage contraction velocities in sinus rh

45 In patients, left atrial appendage contraction velocities measured du

46 Peak left atrial appendage contraction velocities were signif

47 unction at all time intervals as assessed by left atrial appendage contraction velocity (LAACV) was s

48 s transcatheter aortic valve replacement and left atrial appendage device occlusion, is being increas

49 trial fibrillation are depressed relative to left atrial appendage emptying velocities measured durin

50 ersus 4.9 cm, p < 0.0001 and lower mean peak left atrial appendage emptying velocity (LAAEV), 38 vers

51 s and spontaneous echo contrast, we measured left atrial appendage emptying velocity and calculated s

52 ft ventricular diastolic function, and lower left atrial appendage emptying velocity were independent

53 graph-determined transmitral diastolic flow, left atrial appendage emptying, and pulmonary venous flo

54 onary vein, ganglionated plexi ablation, and left atrial appendage excision with optional additional

55 rm follow-up continues to support a role for left atrial appendage exclusion from the central circula

56 s and atrial fibrillation, left atrial size, left atrial appendage flow velocities and thrombus.

57 tients with atrial flutter exhibited greater left atrial appendage flow velocities before cardioversi

58 After cardioversion, left atrial appendage flow velocities decreased compared

59 Left atrial appendages from 239 patients stratified by c

60 The impaired left atrial appendage function after cardioversion was l

61 patients with atrial flutter and to compare left atrial appendage function in the pericardioversion

62 ial fibrillation because of better preserved left atrial appendage function.

63 In this setting, thrombus in the left atrial appendage has been found to be the source of

64 tting typically results from thrombus in the left atrial appendage has led to the development of mech

65 AF the intramyocardial blood vessels of the left atrial appendage have an increased CML presence and

66 significantly higher in blood vessels of the left atrial appendage in AF patients as compared to cont

67 T AF has, for the first time, implicated the left atrial appendage in the pathogenesis of stroke in a

68 ing atrial fibrillation, suggesting that the left atrial appendage is mechanically "stunned."

69 mly assigned to undergo empirical electrical left atrial appendage isolation along with extensive abl

70 ng the effectiveness of empirical electrical left atrial appendage isolation for the treatment of LSP

71 (Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure O

72 ring repeat procedures, empirical electrical left atrial appendage isolation was performed in all pat

73 umflex coronary artery, and catheters in the left atrial appendage, jugular and carotid vessels.

74 rate, or by equivalent test pacing from the left atrial appendage (LAA) at 5% or 50% greater than th

75 standard for the exclusion of thrombi in the left atrial appendage (LAA) before ablation for atrial f

76 This study investigated the left atrial appendage (LAA) by computed tomography (CT)

77 udy was to assess the safety and efficacy of left atrial appendage (LAA) closure in nonvalvular atria

78 ght to determine which surgical technique of left atrial appendage (LAA) closure is most successful b

79 was to determine the efficacy and safety of left atrial appendage (LAA) closure via a percutaneous L

80 Randomized trials of left atrial appendage (LAA) closure with the Watchman de

81 er the empirical electrical isolation of the left atrial appendage (LAA) could improve success at fol

82 the incidence of incomplete ligation of the left atrial appendage (LAA) during mitral valve surgery.

83 Left atrial appendage (LAA) electric isolation is report

84 hort-term effect of a brief episode of AF on left atrial appendage (LAA) emptying velocity is unknown

85 the characterization of left atrial (LA) and left atrial appendage (LAA) flow dynamics in patients wi

86 The left atrial appendage (LAA) has been identified as a pre

87 The left atrial appendage (LAA) is an underestimated site of

88 Prophylactic exclusion of the left atrial appendage (LAA) is often performed during ca

89 The left atrial appendage (LAA) is the source of the vast ma

90 Electric left atrial appendage (LAA) isolation (LAAI) may occur d

91 Transcatheter left atrial appendage (LAA) ligation may represent an al

92 Left atrial appendage (LAA) ligation with the Lariat dev

93 Percutaneous left atrial appendage (LAA) occlusion and novel pharmaco

94 with nonvalvular atrial fibrillation (NVAF), left atrial appendage (LAA) occlusion was noninferior to

95 Left atrial appendage (LAA) procedures have been develop

96 frequency and clinical impact of incomplete left atrial appendage (LAA) sealing and consequent peri-

97 ip of a CHADS(2) score with left atrial (LA)/left atrial appendage (LAA) spontaneous echo contrast, s

98 olic stroke is thought to be associated with left atrial appendage (LAA) thrombi.

99 stroke due almost exclusively to emboli from left atrial appendage (LAA) thrombi.

100 The left atrial appendage (LAA) was snap-frozen in situ afte

101 ostic modality of choice for visualizing the left atrial appendage (LAA).

102 We evaluated left atrial appendage obliteration in high-risk patients

103 ups were novel oral anticoagulants, Watchman left atrial appendage occlusion device (DEVICE), and war

104 of stroke, site-specific therapy directed at left atrial appendage occlusion has been now studied for

105 hythm after cardioversion, and techniques of left atrial appendage occlusion.

106 fibrosis on conduction velocity (CV) in the left atrial appendage of patients with AF.

107 g were performed on DNA from lymphocytes and left atrial appendages of 34 patients (25 with AF).

108 as used to study conduction in the right and left atrial appendages of isolated Langendorff-perfused

109 lesion using differential coronary sinus and left atrial appendage pacing techniques encounters a pit

110 block using differential coronary sinus and left atrial appendage pacing techniques in patients with

111 ontaneous echo contrast (RR 3.7, p < 0.001), left atrial appendage peak flow velocities < or = 20 cm/

112 X2c RNAs were highly correlated in 233 human left atrial appendage samples.

113 Left atrial appendage shear rates were also higher in pa

114 Left atrial appendage stunning also occurs in patients w

115 Left atrial appendage stunning has recently been propose

116 This study sought to determine whether left atrial appendage stunning occurs in patients with a

117 The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic Protection in P

118 ) of follow-up from the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in P

119 rawn predominantly from PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in P

120 The PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in P

121 The multicenter PROTECT AF study (Watchman Left Atrial Appendage System for Embolic Protection in P

122 The Watchman Left Atrial Appendage System for Embolic Protection in P

123 systolic function and regional left atrial (left atrial appendage) systolic function upon resumption

124 amber, as well as the pericardium, right and left atrial appendages, the junction of the right atrium

125 Left atrial appendage thrombosis and embolization is the

126 as inserted after induction of GA to exclude left atrial appendage thrombus, define cardiac function,

127 Left atrial appendage tissue from 33 AF patients and 9 c

128 gned to evaluate the effects of percutaneous left atrial appendage transcatheter occlusion (PLAATO) o

129 s, NYHA functional class, ejection fraction, left atrial appendage velocity, and medications in patie

130 ar) follow-up of Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Preven

131 The PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Preven

132 the PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Preven

133 the PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Preven

134 tral annulus along the posterior base of the left atrial appendage visualized by selective angiograph

135 ve, tricuspid valve, interatrial septum, and left atrial appendage were obtained, followed by a left

136 Thirty-five left atrial appendages were obtained during AF surgery.

137 ctural parameters of the left atrium and the left atrial appendage which have been shown to be associ

138 CVL was higher in left atrial appendages with thick compared with thin int

139 on entropy in the posterior left atrium than left atrial appendage, with the decrease in Shannon entr

140 achieved an adequate seal of the neck of the left atrial appendage without significant effect on the